These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7779144)

  • 1. Mechanisms of the potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes.
    Miyakoda G; Nakayama N; Matsui K; Yabuuchi Y
    Arzneimittelforschung; 1995 Apr; 45(4):471-5. PubMed ID: 7779144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AE0047-mediated calcium channel blocking in vascular smooth muscles.
    Yamanaga K; Shinyama H; Akira T; Iwamoto M; Uchida T; Nakamura N; Kagitani Y
    Gen Pharmacol; 1997 Sep; 29(3):337-43. PubMed ID: 9378237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro.
    Nakayama N; Ikezono K; Ohura M; Yabuuchi Y
    Arzneimittelforschung; 1993 Dec; 43(12):1266-70. PubMed ID: 8141812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator.
    Hirano T; Mori T; Kido M; Toide K; Ohura M; Fujiki H; Orito K; Yoshida K; Ikezono K; Sumida T; Nakayama N; Yabuuchi Y
    Fundam Clin Pharmacol; 1999; 13(6):650-5. PubMed ID: 10626752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
    Salomone S; Godfraind T
    Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pranidipine, a new 1,4-dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta.
    Mori T; Takeuchi T; Ohura M; Miyakoda G; Fujiki H; Orito K; Yoshida K; Hirano T; Yamamura Y; Sumida T; Nakaya Y; Satake H; Hata F
    Mol Cell Biochem; 1998 Jan; 178(1-2):335-43. PubMed ID: 9546618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
    J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pranidipine enhances the action of nitric oxide released from endothelial cells.
    Yang J; Fukuo K; Morimoto S; Niinobu T; Suhara T; Ogihara T
    Hypertension; 2000 Jan; 35(1 Pt 1):82-5. PubMed ID: 10642279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
    Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of S-312, a new calcium channel blocker, on the 1,4-dihydropyridine binding sites in porcine basilar blood vessels and rat aortic smooth muscle cells.
    Mihara S; Fujimoto M
    Jpn J Pharmacol; 1991 Jul; 56(3):249-59. PubMed ID: 1832726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of pranidipine (OPC-13340), a novel 1,4-dihydropyridine derivative Ca-antagonist, on isolated porcine coronary contraction and acute myocardial ischemia in the pig].
    Ohura M; Mori T; Watanabe K; Ikezono K; Nakayama N; Tominaga M; Yabuuchi Y
    Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):101-9. PubMed ID: 8144102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blocking properties of SM-6586 in rat heart and brain as assessed by radioligand binding assay.
    Qu YL; Sugiyama K; Nagatomo T; Maniwa T; Miyagishi A
    Jpn J Pharmacol; 1993 Oct; 63(2):165-9. PubMed ID: 8283826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation.
    Mori T; Takase H; Toide K; Hirano T; Kambe T; Nakayama N; Schwartz A
    Cardiovasc Drug Rev; 2001; 19(1):1-8. PubMed ID: 11314598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
    Feron O; Wibo M; Christen MO; Godfraind T
    Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
    Miyoshi K; Kanda A; Miyake H; Ichihara K; Kamei H; Nagasaka M
    Eur J Pharmacol; 1993 Jul; 238(2-3):139-48. PubMed ID: 7691619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological and radioligand binding studies of elgodipine and derivatives in portal vein myocytes.
    Lepretre N; Arnaudeau S; Mironneau J; Rakotoarisoa L; Mironneau C; Galiano A
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1209-15. PubMed ID: 7996428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of pranidipine on N-type voltage-dependent Ca2+ channels in mice.
    Murakami M; Mori T; Nakagawasai O; Hagiwara K; Sakurada Y; Mobarakeh II; Murata A; Yamadera F; Miyoshi I; Tan-No K; Yanai K; Tadano T; Iijima T
    Neurosci Lett; 2004 Aug; 367(1):118-22. PubMed ID: 15308311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.